Ability of tumor cells to resist humoral vs. cell-mediated immune attack is controlled by different membrane physical properties.
D000818:Animals; D000906:Antibodies; D000917:Antibody Formation / Q000187:drug effects; D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003602:Cytotoxicity, Immunologic; D004317:Doxorubicin / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006854:Hydrocortisone / Q000494:pharmacology; D007111:Immunity, Cellular / Q000187:drug effects; D012515:Mast-Cell Sarcoma / Q000276:immunology*; D051379:Mice; D012513:Sarcoma, Experimental / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000906:Antibodies; D004317:Doxorubicin; D006854:Hydrocortisone; D004837:Epinephrine